Re: Farmas USA
GILD
Corrijo, sí que hay news...
New chief at Gilead
Effective March 10, Gilead Sciences (NASDAQ:GILD) Chairman and CEO John Martin, Ph.D. will transition to the role of Executive Chairman and President & COO; John Milligan, Ph.D. will be promoted to CEO. Dr. Martin joined the firm in 1990 and was appointed CEO in 1996 and Chairman in 2008. Dr. Milligan also joined the company in 1990. He was appointed COO in 2007 and President in 2008.
Re: Farmas USA
Re: Farmas USA
Re: Farmas USA
Re: Farmas USA
Bueno , hoy se me ha escapado HZNP por 4 centavicos de nada ... mala suerte, hubiera sido un buen metesaca.
Pero con ver el sector verdear ya es suficiente regalo hoy, solo queda ver que dure para lo que queda de dia ...
Re: Farmas USA
NVAX
Yo sí que estoy loco, me imagino al Cramer apartando las nubes a manotazos para que veamos el sol:))
Re: Farmas USA
NVAX
Es muy pronto, pero apunta maneras:)